Predictmedix AI looks back at 2025

Executive Summary

• Predictmedix AI Inc. released its 2025 Year-End Corporate Update, highlighting the successful conclusion of 2025 with over 500,000 real-world scans of its SmartHealth AI stations, validating the scalability and commercial readiness of its proprietary AI engine.
• The company executed a multivertical growth strategy across SmartHealth AI stations, clinical-trial AI platforms, and consumer mobile applications, leveraging hybrid quantum-classical algorithms to improve signal clarity and reduce bias on standard hardware.
• To accelerate innovation, the company announced the issuance of 12.3 million common shares to nine consultants and advisers, aligning contributors with long-term value creation while expanding global investor engagement through European roadshows.

Key Details

• Operational Metrics: Surpassed 500,000 real-world scans in 2025, validating the scalability and resilience of SmartHealth AI stations across diverse environments and populations.
• Technology Development: Enhanced AI-driven health screening platforms using hybrid quantum-classical algorithms to achieve sharper noise reduction, improved signal clarity, and more accurate screening across diverse populations (lighting, skin tones, occlusions) without specialized quantum devices.
• Investor Engagement: Headlined targeted European investor roadshows in Hungary, Croatia, and Serbia, and presented at the MK Investment Conference in Munich, Germany, engaging institutional investors, family offices, and strategic capital partners.
• Strategic Structure: Continued execution of a multivertical growth strategy built around a single proprietary core AI engine powering three verticals:
  1. SmartHealth AI stations for workplace, institutional, and health care screening.
  2. Clinical-trial AI platforms for patient matching, simulation, and trial optimization.
  3. Consumer mobile applications for scalable vital and wellness screening.
• Equity Issuance: Plans to issue 12.3 million common shares to nine consultants and advisers as part of strategic collaborations to accelerate innovation and execution.
• 2026 Priorities:
  • Scaling SmartHealth AI station deployments globally.
  • Expanding adoption of mobile digital health solutions.
  • Accelerating U.S. and international commercialization.
  • Advancing recurring revenue opportunities across AI platforms.
  • Further integrating quantum-inspired computational algorithms to optimize signal fidelity and reduce detection bias.

Notable Quotes

• "Throughout 2025, Predictmedix AI enhanced the performance, scalability and real-world effectiveness of its AI-driven health screening platforms while pioneering quantum-inspired computational enhancements."
• "SmartHealth has proved the effectiveness of contactless, validated screening while continuously generating high-value real-world data."
• "These engagements increased awareness of Predictmedix AI's proprietary core AI engine, multivertical growth strategy and global commercialization road map."